Photronics Reports First Quarter Fiscal 2026 Results
Commenting on the first quarter performance, Chairman and CEO
First Quarter Fiscal 2026 Results
- Revenue was
$225.1 million , up 6.1% year-over-year and up 4.3% sequentially. - GAAP Net income attributable to
Photronics, Inc. shareholders was$42.9 million , or$0.74 per diluted share, compared with$42.9 million , or$0.68 per diluted share, in the first quarter of 2025 and$61.8 million , or$1.07 per diluted share, in the fourth quarter of 2025. - Non-GAAP Net income attributable to
Photronics, Inc. shareholders was$35.7 million , or$0.61 per diluted share, compared with$32.4 million , or$0.52 per diluted share in the first quarter of 2025 and$34.6 million , or$0.60 per diluted share, in the fourth quarter of 2025. - IC revenue was
$165.3 million , an increase of 7% year-over-year and up 5% sequentially. - FPD revenue was
$59.8 million , an increase of 3% both year-over-year and sequentially. - Cash, cash equivalents and short-term investments at the end of the quarter were
$636.9 million , of which$459.1 million was associated with our Joint Ventures, of which we own 50.01%. - Cash generated from operating activities was
$97.3 million , and cash invested in organic growth through capital expenditures was$47.6 million .
Second Quarter Fiscal 2026 Guidance
For the second quarter of fiscal 2026, Photronics expects Revenue to be between
Webcast
A webcast to discuss these results is scheduled for
About Photronics
Photronics is a leading worldwide manufacturer of integrated circuit (IC) and flat panel display (FPD) photomasks, which are high precision photographic quartz or glass plates that contain microscopic images of electronic circuits. Photomasks are a key element in the manufacture of ICs and FPDs and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates. Founded in 1969, Photronics has been a trusted photomask supplier for over 56 years. The company operates 11 strategically located manufacturing facilities in
Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements” regarding our industry, our strategic position, and our financial and operating results. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, performance or achievements to differ materially. Please refer to Item 1A “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
Non-GAAP Net Income attributable to
Totals presented may not sum due to rounding.
| Condensed Consolidated Statements of Income | ||||||||||||
| (in thousands, except per share amounts) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended | ||||||||||||
| 2026 | 2025 | 2025 | ||||||||||
| Revenue | $ | 225,066 | $ | 215,770 | $ | 212,138 | ||||||
| Cost of goods sold | 146,364 | 140,236 | 136,603 | |||||||||
| Gross Profit | 78,702 | 75,534 | 75,535 | |||||||||
| Gross margin % | 35.0 | % | 35.0 | % | 35.6 | % | ||||||
| Operating Expenses: | ||||||||||||
| Selling, general and administrative | 21,311 | 20,001 | 19,101 | |||||||||
| Research and development | 2,588 | 3,185 | 4,257 | |||||||||
| Total Operating Expenses | 23,899 | 23,186 | 23,358 | |||||||||
| Other operating Income (expense) | 56 | (241 | ) | - | ||||||||
| Operating Income | 54,859 | 52,107 | 52,177 | |||||||||
| Operating Margin | 24.4 | % | 24.1 | % | 24.6 | % | ||||||
| Other income, net | 19,673 | 23,855 | 24,981 | |||||||||
| Income Before Income Tax Provision | 74,532 | 75,962 | 77,158 | |||||||||
| Income tax provision (benefit) | 14,355 | (2,659 | ) | 18,901 | ||||||||
| Net Income | 60,177 | 78,621 | 58,257 | |||||||||
| Net income attributable to noncontrolling interests | 17,238 | 16,820 | 15,406 | |||||||||
| Net income attributable to |
$ | 42,939 | $ | 61,801 | $ | 42,851 | ||||||
| Earnings per share attributed to |
||||||||||||
| Basic | $ | 0.74 | $ | 1.07 | $ | 0.69 | ||||||
| Diluted | $ | 0.74 | $ | 1.07 | $ | 0.68 | ||||||
| Weighted-average number of common shares outstanding: | ||||||||||||
| Basic | 57,794 | 57,600 | 62,093 | |||||||||
| Diluted | 58,390 | 57,977 | 62,661 | |||||||||
| Condensed Consolidated Balance Sheets | ||||||||
| (in thousands) | ||||||||
| (Unaudited) | ||||||||
| 2026 |
2025 |
|||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 544,133 | $ | 492,256 | ||||
| Short-term investments | 92,738 | 95,909 | ||||||
| Accounts receivable | 199,490 | 195,921 | ||||||
| Inventories | 62,653 | 61,767 | ||||||
| Other current assets | 47,235 | 44,199 | ||||||
| Total current assets | 946,249 | 890,052 | ||||||
| Property, plant and equipment, net | 894,620 | 854,436 | ||||||
| Other assets | 60,550 | 60,046 | ||||||
| Total assets | $ | 1,901,419 | $ | 1,804,534 | ||||
| Liabilities and Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of long-term debt | $ | 11 | $ | 11 | ||||
| Accounts payable and accrued liabilities | 206,638 | 165,862 | ||||||
| Total current liabilities | 206,649 | 165,873 | ||||||
| Long-term debt | 10 | 13 | ||||||
| Other liabilities | 44,839 | 41,341 | ||||||
| Equity: | ||||||||
| 1,211,390 | 1,173,589 | |||||||
| Noncontrolling interests | 438,531 | 423,718 | ||||||
| Total equity | 1,649,921 | 1,597,307 | ||||||
| Total liabilities and equity | $ | 1,901,419 | $ | 1,804,534 | ||||
| Condensed Consolidated Statements of Cash Flows | ||||||||
| (in thousands) | ||||||||
| (Unaudited) | ||||||||
| Three Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 60,177 | $ | 58,257 | ||||
| Adjustments to reconcile net income to net cash | ||||||||
| provided by operating activities: | ||||||||
| Depreciation and amortization | 19,802 | 20,792 | ||||||
| Share-based compensation | 2,851 | 3,334 | ||||||
| Changes in operating assets, liabilities and other | 14,424 | (3,917 | ) | |||||
| Net cash provided by operating activities | 97,254 | 78,466 | ||||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (47,635 | ) | (35,200 | ) | ||||
| Purchases of short-term investments | (36,611 | ) | - | |||||
| Proceeds from maturities of short-term investments | 41,483 | 41,482 | ||||||
| Government incentives | 2,567 | 620 | ||||||
| Other | (80 | ) | (57 | ) | ||||
| Net cash (used in) provided by investing activities | (40,276 | ) | 6,845 | |||||
| Cash flows from financing activities: | ||||||||
| Repayments of debt | (3 | ) | (15,343 | ) | ||||
| Common stock repurchases | - | (4,573 | ) | |||||
| Proceeds from share-based arrangements | 752 | 1,433 | ||||||
| Net settlements of restricted stock awards | - | (1,995 | ) | |||||
| Net cash provided by (used in) financing activities | 749 | (20,478 | ) | |||||
| Effects of exchange rate changes on cash, cash equivalents, and restricted cash | (5,915 | ) | (21,202 | ) | ||||
| Net increase in cash, cash equivalents, and restricted cash | 51,812 | 43,631 | ||||||
| Cash, cash equivalents, and restricted cash, beginning of period | 495,113 | 601,243 | ||||||
| Cash, cash equivalents, and restricted cash, end of period | 546,925 | 644,874 | ||||||
| Less: Ending restricted cash | 2,792 | 2,674 | ||||||
| Cash and cash equivalents at end of period | $ | 544,133 | $ | 642,200 | ||||
| Reconciliation of |
|||||||||||
| (in thousands, except per share amounts) | |||||||||||
| (Unaudited) | |||||||||||
| Three Months ended | |||||||||||
| 2026 | 2025 | 2025 | |||||||||
| $ | 42,939 | $ | 61,801 | $ | 42,851 | ||||||
| FX (gain) loss | (12,865 | ) | (18,615 | ) | (18,443 | ) | |||||
| Estimated tax effects of FX (gain) loss | 2,553 | 4,781 | 5,152 | ||||||||
| Estimated noncontrolling interest effects of above | 3,032 | 3,341 | 2,823 | ||||||||
| Reversal of deferred tax valuation allowance | - | (16,751 | ) | - | |||||||
| Non-GAAP net income attributable to |
$ | 35,659 | $ | 34,557 | $ | 32,383 | |||||
| Weighted-average number of common shares outstanding - Diluted | 58,390 | 57,977 | 62,661 | ||||||||
| $ | 0.74 | $ | 1.07 | $ | 0.68 | ||||||
| Effects of non-GAAP adjustments above | (0.13 | ) | (0.47 | ) | (0.16 | ) | |||||
| Non-GAAP diluted earnings per share attributable to |
$ | 0.61 | $ | 0.60 | $ | 0.52 | |||||

For Further Information:Ted Moreau VP, Investor Relations 469.395.8175 tmoreau@photronics.com
Source: Photronics, Inc.




